Search research articles
Contact Us
Filters
Showing results (11-20 of 119) with videos related to
Page
of 12
Sort By:
Blood
|
February 1, 1987
Relationship of the hematopoietic cycle to the combined activities of a stimulator and a short-lived inhibitor
P J Burke, J E Karp
Pharmaceutical Research
|
April 1, 1988
The effect of azone on ocular levobunolol absorption: calculating the area under the curve and its standard error using tissue sampling compartments
D D Tang-Liu, P J Burke
Journal of the National Cancer Institute
|
September 1, 1978
BN rat myeloid leukemia transferred to the (LEW x BN)F1 rat
W P Vaughn, P J Burke, J Jung
Cancer
|
March 1, 1980
Long chemotherapy-free remissions after single-cycle timed-sequential chemotherapy for acute myelocytic leukemia
W P Vaughan, J E Karp, P J Burke
Seminars in Oncology
|
June 1, 1987
An in vitro model to predict clinical response in adult acute myelogenous leukemia
J E Karp, R C Donehower, P J Burke
Cancer Treatment Reports
|
September 1, 1986
Pharmacology and toxicity of high-dose cytarabine by 72-hour continuous infusion
R C Donehower, J E Karp, P J Burke
Blood
|
June 1, 1977
Induction of serum stimulation and plasma cell proliferation during chemotherapy of multiple myeloma
J E Karp, P J Burke, R L Humphrey
Leukemia
|
November 1, 1994
Identification of growth factor-responsive acute myelogenous leukemia based on factor-dependence for survival and proliferation
S D Gore, L J Weng, P J Burke
Leukemia & Lymphoma
|
July 31, 1998
Impact of exogenous growth factors on proliferation and chemosensitivity of minimal residual acute myeloid leukemia
S D Gore, P J Burke, L J Weng
Leukemia
|
August 1, 1990
Effects of rhGM-CSF on intracellular ara-C pharmacology in vitro in acute myelocytic leukemia: comparability with drug-induced humoral stimulatory activity
J E Karp, P J Burke, R C Donehower
Page
of 12
Search research articles
Search
Showing results (11-20 of 119) with videos related to
Sort By:
Page
of 12
Blood
|
February 1, 1987
Relationship of the hematopoietic cycle to the combined activities of a stimulator and a short-lived inhibitor
P J Burke, J E Karp
Pharmaceutical Research
|
April 1, 1988
The effect of azone on ocular levobunolol absorption: calculating the area under the curve and its standard error using tissue sampling compartments
D D Tang-Liu, P J Burke
Journal of the National Cancer Institute
|
September 1, 1978
BN rat myeloid leukemia transferred to the (LEW x BN)F1 rat
W P Vaughn, P J Burke, J Jung
Cancer
|
March 1, 1980
Long chemotherapy-free remissions after single-cycle timed-sequential chemotherapy for acute myelocytic leukemia
W P Vaughan, J E Karp, P J Burke
Seminars in Oncology
|
June 1, 1987
An in vitro model to predict clinical response in adult acute myelogenous leukemia
J E Karp, R C Donehower, P J Burke
Cancer Treatment Reports
|
September 1, 1986
Pharmacology and toxicity of high-dose cytarabine by 72-hour continuous infusion
R C Donehower, J E Karp, P J Burke
Blood
|
June 1, 1977
Induction of serum stimulation and plasma cell proliferation during chemotherapy of multiple myeloma
J E Karp, P J Burke, R L Humphrey
Leukemia
|
November 1, 1994
Identification of growth factor-responsive acute myelogenous leukemia based on factor-dependence for survival and proliferation
S D Gore, L J Weng, P J Burke
Leukemia & Lymphoma
|
July 31, 1998
Impact of exogenous growth factors on proliferation and chemosensitivity of minimal residual acute myeloid leukemia
S D Gore, P J Burke, L J Weng
Leukemia
|
August 1, 1990
Effects of rhGM-CSF on intracellular ara-C pharmacology in vitro in acute myelocytic leukemia: comparability with drug-induced humoral stimulatory activity
J E Karp, P J Burke, R C Donehower
Page
of 12